GoAI
Get started
CAMP4 Therapeutics Corporation logo

CAMP4 Therapeutics Corporation

CAMP

NASDAQHealthcareBiotechnology

Open in GoAI

Previous close

$4.48

+$0.02 · +0.45%

Aug 21, 4:00 PM ET

CAMP company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

58

Fair Value

Momentum

58

Neutral

Sentiment

61

Bullish

Risk resilience

37

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Industry
Biotechnology
Sector
Healthcare
Headquarters
US

Market position

Day range

Current $4.48

52-week range

Current $4.48

Open
$4.405
Previous close
$4.46
Volume
126.86K
Market cap
95.16M USD
50-day average
$4.1132
+8.92% above average
200-day average
$4.4816
-0.04% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
78.69M USD
EV / EBITDA
-1.56×
Earnings yield
-43.17%
Free cash flow yield
-16.02%

Profitability & efficiency

Return on equity
-168.55%
Return on assets
-68.25%
Return on invested capital
-50.75%

Financial health

Current ratio
7.35×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends1592%-4377%-10346%-16315%Gross margin, FY2021: 41.20%Gross margin, FY2022: 36.96%Gross margin, FY2023: 100.00%Gross margin, FY2024: 100.00%Gross margin, FY2025: 53.14%Operating margin, FY2021: -5.18%Operating margin, FY2022: -8.37%Operating margin, FY2023: -14822.57%Operating margin, FY2024: -8142.33%Operating margin, FY2025: -1488.31%Net margin, FY2021: -10.53%Net margin, FY2022: -11.02%Net margin, FY2023: -14083.14%Net margin, FY2024: -7943.40%Net margin, FY2025: -2298.54%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 41.20%. Gross margin FY2022 36.96%. Gross margin FY2023 100.00%. Gross margin FY2024 100.00%. Gross margin FY2025 53.14%. Operating margin FY2021 -5.18%. Operating margin FY2022 -8.37%. Operating margin FY2023 -14822.57%. Operating margin FY2024 -8142.33%. Operating margin FY2025 -1488.31%. Net margin FY2021 -10.53%. Net margin FY2022 -11.02%. Net margin FY2023 -14083.14%. Net margin FY2024 -7943.40%. Net margin FY2025 -2298.54%.

Income trends

Revenue

3.5M USD+436.50%

Operating income

−52.06M USD+1.93%

Net income

−80.4M USD-55.25%
Income trends across reported periods333.46M USD182.97M USD32.47M USD−118.03M USDRevenue, FY2021: 295.84M USDRevenue, FY2022: 294.95M USDRevenue, FY2023: 350K USDRevenue, FY2024: 652K USDRevenue, FY2025: 3.5M USDOperating income, FY2021: −15.31M USDOperating income, FY2022: −24.69M USDOperating income, FY2023: −51.88M USDOperating income, FY2024: −53.09M USDOperating income, FY2025: −52.06M USDNet income, FY2021: −31.15M USDNet income, FY2022: −32.49M USDNet income, FY2023: −49.29M USDNet income, FY2024: −51.79M USDNet income, FY2025: −80.4M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 295.84M USD. Revenue FY2022 294.95M USD. Revenue FY2023 350K USD. Revenue FY2024 652K USD. Revenue FY2025 3.5M USD. Operating income FY2021 −15.31M USD. Operating income FY2022 −24.69M USD. Operating income FY2023 −51.88M USD. Operating income FY2024 −53.09M USD. Operating income FY2025 −52.06M USD. Net income FY2021 −31.15M USD. Net income FY2022 −32.49M USD. Net income FY2023 −49.29M USD. Net income FY2024 −51.79M USD. Net income FY2025 −80.4M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue3.5M USD652K USD350K USD294.95M USD295.84M USD
Cost of goods sold1.64M USD——185.94M USD173.95M USD
Gross profit1.86M USD652K USD350K USD109.01M USD121.89M USD
Research and development38.2M USD38.82M USD40.62M USD24.57M USD28.44M USD
Selling, general, and administrative17.36M USD14.92M USD11.61M USD99.21M USD100.9M USD
Operating expenses53.92M USD53.74M USD52.23M USD133.7M USD134.76M USD
Interest income2.17M USD1.33M USD2.81M USD989K USD—
Interest expense———6.26M USD15.32M USD
Depreciation and amortization1.64M USD1.7M USD1.68M USD—22.8M USD
Operating income−52.06M USD−53.09M USD−51.88M USD−24.69M USD−15.31M USD
Net income−80.4M USD−51.79M USD−49.29M USD−32.49M USD−31.15M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
33%
4 beats, 8 misses, 0 met estimates
Average EPS surprise
-750.58%
12 comparable reports
Latest EPS result
-0.58
Estimate -0.21 · Miss by 174.32%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates-0.18-8.82-17.47-26.11Q1 '25MissQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26Miss
Q1 2025, reported Feb 20, 2025: actual -24.19, estimate -0.82, surprise -2850.00%, Miss. Q1 2025, reported Mar 27, 2025: actual -0.77, estimate -0.91, surprise +15.38%, Beat. Q2 2025, reported May 13, 2025: actual -0.62, estimate -0.7, surprise +11.43%, Beat. Q3 2025, reported Aug 14, 2025: actual -0.62, estimate -0.67, surprise +7.46%, Beat. Q4 2025, reported Nov 6, 2025: actual -0.55, estimate -0.47, surprise -17.02%, Miss. Q1 2026, reported Mar 5, 2026: actual -0.87, estimate -0.31, surprise -180.65%, Miss. Q2 2026, reported May 7, 2026: actual -0.32, estimate -0.21, surprise -52.38%, Miss. Q3 2026, reported Aug 13, 2026: actual -0.58, estimate -0.211, surprise -174.32%, Miss.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.9M1.33M756.27K182.33KQ1 '25EstimateQ1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26MissQ2 '26BeatQ3 '26Beat
Q1 2025, reported Feb 20, 2025: actual —, estimate 250K USD, surprise —, Comparison unavailable. Q1 2025, reported Mar 27, 2025: actual 652K USD, estimate 676K USD, surprise -3.55%, Miss. Q2 2025, reported May 13, 2025: actual 858K USD, estimate 214.5K USD, surprise +300.00%, Beat. Q3 2025, reported Aug 14, 2025: actual 1.5M USD, estimate 571.78K USD, surprise +161.81%, Beat. Q4 2025, reported Nov 6, 2025: actual 795K USD, estimate 433.33K USD, surprise +83.46%, Beat. Q1 2026, reported Mar 5, 2026: actual 300K USD, estimate 475.2K USD, surprise -36.87%, Miss. Q2 2026, reported May 7, 2026: actual 1.29M USD, estimate 1.12M USD, surprise +15.74%, Beat. Q3 2026, reported Aug 13, 2026: actual 1.78M USD, estimate 1.62M USD, surprise +9.81%, Beat.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

24 ratings
Strong buy00%
Buy1771%
Hold625%
Sell14%
Strong sell00%

CAMP peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding CAMP

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
3.93M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
2.21M
Weight
0.00%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
iShares Russell 2000 Growth ETF logoiShares Russell 2000 Growth ETFIWO
Market value
1.33M
Weight
0.01%
AUM
15.16B USD
Expense ratio
0.24%
Price / 1D
$387.37+1.24%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
1.23M
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
611.17K
Weight
0.00%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$121.25+0.74%
iShares Micro-Cap ETF logoiShares Micro-Cap ETFIWC
Market value
492.08K
Weight
0.03%
AUM
1.53B USD
Expense ratio
0.60%
Price / 1D
$198.39+1.10%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF logoGoldman Sachs ActiveBeta U.S. Small Cap Equity ETFGSSC
Market value
224.28K
Weight
0.02%
AUM
1.09B USD
Expense ratio
0.20%
Price / 1D
$91.32+0.82%
Vanguard Russell 2000 Growth ETF logoVanguard Russell 2000 Growth ETFVTWG
Market value
117.9K
Weight
0.01%
AUM
1.7B USD
Expense ratio
0.06%
Price / 1D
$282.73+1.21%

Continue in GoAI

Research CAMP

research.disclaimer